NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

argenx SE (BR: ARGX)

 
ARGX Technical Analysis
5
As on 26th Mar 2025 ARGX STOCK Price closed @ 545.80 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 395.66 & Strong Buy for SHORT-TERM with Stoploss of 423.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ARGXSTOCK Price

Open 559.00 Change Price %
High 560.60 1 Day -13.20 -2.36
Low 542.20 1 Week -14.40 -2.57
Close 545.80 1 Month -77.80 -12.48
Volume 68830 1 Year 95.00 21.07
52 Week High 653.60 | 52 Week Low 298.70
 
BR Belgium Most Active Stocks
SCHD 27.59 -91.89%
OPTI 0.01 %
ABI 57.10 -0.17%
BOTHE 0.29 70.59%
ACPH 0.89 0.00%
KBC 87.90 -0.72%
UMI 9.21 -2.75%
NYXH 8.68 -17.73%
AGS 56.15 -0.97%
UCB 167.50 -4.42%
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
TESB 25.25 7.91%
FLOB 660.00 4.76%
TITC 42.00 3.96%
TITC 42.00 3.96%
ANT 6.41 3.22%
ANT 6.41 3.22%
ELI 84.00 2.44%
ELI 84.00 2.44%
ELI 84.00 2.44%
 
BR Belgium Top Losers Stocks
SCHD 27.59 -91.89%
BELR 1.93 -74.27%
BELR 1.93 -74.27%
SOFT 0.74 -19.57%
SOFT 0.74 -19.57%
NYXH 8.68 -17.73%
NYXH 8.68 -17.73%
NEWT 1.80 -9.55%
NEWT 1.80 -9.55%
PIC 66.00 -6.25%
 
 
ARGX
Daily Charts
ARGX
Intraday Charts
Whats New @
Bazaartrend
ARGX
Free Analysis
 
ARGX Important Levels Intraday
RESISTANCE581.26
RESISTANCE569.89
RESISTANCE562.86
RESISTANCE555.83
SUPPORT535.77
SUPPORT528.74
SUPPORT521.71
SUPPORT510.34
 
ARGX Forecast March 2025
4th UP Forecast914.05
3rd UP Forecast795.95
2nd UP Forecast722.95
1st UP Forecast649.95
1st DOWN Forecast441.65
2nd DOWN Forecast368.65
3rd DOWN Forecast295.65
4th DOWN Forecast177.55
 
ARGX Weekly Forecast
4th UP Forecast611.32
3rd UP Forecast590.31
2nd UP Forecast577.32
1st UP Forecast564.33
1st DOWN Forecast527.27
2nd DOWN Forecast514.28
3rd DOWN Forecast501.29
4th DOWN Forecast480.28
 
ARGX Forecast2025
4th UP Forecast1291.55
3rd UP Forecast1052.38
2nd UP Forecast904.55
1st UP Forecast756.72
1st DOWN Forecast334.89
2nd DOWN Forecast187.05
3rd DOWN Forecast39.22
4th DOWN Forecast-199.95
 
 
ARGX Other Details
Segment EQ
Market Capital 12356247552.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ARGX Address
ARGX
 
ARGX Latest News
 
Your Comments and Response on argenx SE
 
ARGX Business Profile
argenx SE, a clinical-stage biotechnology company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases, hematology, and cancer. It is developing its lead product candidate, efgartigimod, for the treatment of patients with myasthenia gravis; immune thrombocytopenia in Phase III; pemphigus vulgaris in Phase III; chronic inflammatory demyelinating polyneuropathy in Phase III; and ENHANZE SC in pre-clinical stages. The company is also developing cusatuzumab in Phase II clinical stage in hematological cancer indications; ARGX-117 in phase I clinical trial with therapeutic potential in both orphan and large autoimmune inflammatory diseases; and preclinical products, including ARGX-118 for airway inflammation. Its partnered product candidates include ARGX-112 for treating skin inflammation, ARGX-116 for the treatment of dyslipidemia, and ARGX-115 for cancer immunotherapy, which are in Phase I clinical stages; and ARGX-114 for treating fibrosisand ARGX-119 for treating neuromuscular indications, which are in preclinical stage. The company has strategic partnership with AbbVie S.À.R.L. and LEO Pharma A/S; and collaboration agreement with Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. Address: Willemstraat 5, Breda, Netherlands, 4811 AH
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service